Cargando…

Studies on atherogenesis: the reaction of the corneal model to repeated injections of lipoprotein-rich and lipoprotein-poor homologous serum.

Detalles Bibliográficos
Autores principales:	Grauer, L. E., Waters, L. L.
Formato:	Texto
Lenguaje:	English
Publicado:	Yale Journal of Biology and Medicine 1972
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2591848/ https://www.ncbi.nlm.nih.gov/pubmed/5020568

Ejemplares similares

The Precipitation of Serum Lipoproteins by Gelatin
por: Amenta, J. S., et al.
Publicado: (1960)

Modified Lipoproteins Induce Arterial Wall Inflammation During Atherogenesis
por: Lorey, Martina B., et al.
Publicado: (2022)

Removal of serum lipoproteins from the cornea in vivo.
por: Waters, L. L.
Publicado: (1968)

‘Triglyceride effect’ on the dynamics of plasma lipoproteins and its possible link to atherogenesis
por: Sheriff, Dhastagir Sultan, et al.
Publicado: (2012)

Levels of Injected Serum Lipids Associated with Lipophagic Corneal Reactions
por: Waters, Levin L.
Publicado: (1964)

The Precipitation of Serum Lipoproteins by Mucopolysaccharides Extracted from Aortic Tissue
por: Amenta, J. S., et al.
Publicado: (1960)

Atherogenesis: Initiating Factors
por: Waters, L. L.
Publicado: (1974)

Oxidized Low-Density Lipoprotein Contributes to Atherogenesis via Co-activation of Macrophages and Mast Cells
por: Chen, Chong, et al.
Publicado: (2015)

Atherogenesis in Psoriasis: Evaluation of the Serum Activities of Non-high-density Lipoprotein Cholesterol and Other Lipids Among Newly Diagnosed Psoriasis Patients
por: Thungaturthi, Sudhakar, et al.
Publicado: (2019)

Long Non-Coding RNAs Link Oxidized Low-Density Lipoprotein With the Inflammatory Response of Macrophages in Atherogenesis
por: Yan, Youyou, et al.
Publicado: (2020)

Editorial: Implications of lipids and modified lipoproteins in atherogenesis: from mechanisms towards novel diagnostic and therapeutic targets
por: Kraler, Simon, et al.
Publicado: (2023)

Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis
por: Zhang, Bai-Hui, et al.
Publicado: (2022)

PCSK9 and triglyceride-rich lipoprotein metabolism
por: Druce, Irena, et al.
Publicado: (2015)

Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?
por: Dallinga-Thie, Geesje M., et al.
Publicado: (2016)

Effect of losartan and spironolactone on triglyceride-rich lipoproteins in diabetic nephropathy
por: Srivastava, Anand, et al.
Publicado: (2016)

Investigating the Role of Endothelial Glycogen Synthase Kinase3α/β in Atherogenesis in Low Density Lipoprotein Receptor Knockout Mice
por: Mastrogiacomo, Lauren, et al.
Publicado: (2022)

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
por: Chapman, M. John, et al.
Publicado: (2011)

Serum lipoproteins attenuate macrophage activation and Toll-Like Receptor stimulation by bacterial lipoproteins
por: Bas, Sylvette, et al.
Publicado: (2010)

Tamoxifen, serum lipoproteins and cardiovascular risk.
por: Bruning, P. F., et al.
Publicado: (1988)

Profoundly Disturbed Lipoproteins in Cirrhotic Patients: Role of Lipoprotein-Z, a Hepatotoxic LDL-like Lipoprotein
por: van den Berg, Eline H., et al.
Publicado: (2022)

Triglyceride-rich lipoproteins prevent septic death in rats
Publicado: (1995)

Managing of Dyslipidaemia Characterized by Accumulation of Triglyceride-Rich Lipoproteins
por: Visser, Jolien, et al.
Publicado: (2022)

Cholesterol Remnants, Triglyceride-Rich Lipoproteins and Cardiovascular Risk
por: Baratta, Francesco, et al.
Publicado: (2023)

Triglyceride-Rich Lipoproteins and Remnant Cholesterol in Cardiovascular Disease
por: Heo, Ji Hye, et al.
Publicado: (2023)

Triglyceride-Rich Lipoprotein Metabolism: Key Regulators of Their Flux
por: Gugliucci, Alejandro
Publicado: (2023)

An Intriguing and Important Concept Relevant to Oxidized Low-Density Lipoprotein and Atherogenesis is Still Problematic for its Contribution to the Better Understanding of Clinical Atherosclerosis
por: Yoshida, Hiroshi
Publicado: (2018)

Human Lipoproteins at Model Cell Membranes: Effect of Lipoprotein Class on Lipid Exchange
por: Browning, K. L., et al.
Publicado: (2017)

INHIBITION OF LIPOPROTEIN LIPASE ACTIVITY FOLLOWING INJECTION OF PITUITARY EXTRACTS INTO RABBITS
por: Kellner, Aaron, et al.
Publicado: (1960)

Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank study
por: Björnson, Elias, et al.
Publicado: (2023)

Lipoprotein(a): An Enigmatic Sheep in the Lipoprotein Herd
por: Shapiro, Michael D., et al.
Publicado: (2020)

Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease
por: Toth, Peter P
Publicado: (2016)

Triglyceride-Rich Lipoproteins and Novel Targets for Anti-atherosclerotic Therapy
por: Reiner, Željko
Publicado: (2018)

Endothelial lipase mediates efficient lipolysis of triglyceride-rich lipoproteins
por: Khetarpal, Sumeet A., et al.
Publicado: (2021)

The Role of Triglyceride-rich Lipoproteins and Their Remnants in Atherosclerotic Cardiovascular Disease
por: Gabani, Mohanad, et al.
Publicado: (2023)

Serum Lipoprotein Changes in Dogs with Renal Disease
por: Behling‐Kelly, E.
Publicado: (2014)

The potential role of serum lipoprotein in children with sepsis
por: Wu, Jiabo, et al.
Publicado: (2023)

Dietary-Induced Elevations of Triglyceride-Rich Lipoproteins Promote Atherosclerosis in the Low-Density Lipoprotein Receptor Knockout Syrian Golden Hamster
por: Lin, Xiao, et al.
Publicado: (2021)

Lipoprotein (a): Recent Updates on a Unique Lipoprotein
por: Saeed, Anum, et al.
Publicado: (2021)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
por: Katsiki, Niki, et al.
Publicado: (2023)

Serum Lipid, Lipoprotein and Oxidatively Modified Low Density Lipoprotein Levels in Active or Inactive Patients with Behçet's Disease
por: Cimen, Fuat, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_85bkf5e0mikq57lhdl7bnjnhl7